The groundbreaking therapy of this peptide represents a exciting advance in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide253019.theisblog.com/42443804/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment